Kurs & Likviditet
|Lista||First North Finland|
4 May 2021 at 9:30 a.m. (Finnish time)
Nightingale Health Oyj restructures its Management Team and announces a strategic partnership with Reaktor to accelerate the implementation of its global expansion plan. The company's Chief R&D Officer Dr. Salla Ruosaari has been appointed to lead the company's product organization, and the company's Chief Product Officer Osma Ahvenlampi will be leaving the company to pursue other career opportunities.
In her role, Ruosaari is responsible for developing services based on the company's Health Data Platform and delivering such services to customers using superior digital solutions. With this change, Nightingale's key assets will be even more integrated to rapidly build products and create value for Nightingale's partners and consumer customers. The company's product organization will be further strengthened by the strategic partnership with Reaktor.
After the changes, members of the Management Team are CEO Teemu Suna, Chief Operation Officer Satu Saksman, Chief Technology Officer Antti Kangas, Chief R&D Officer Salla Ruosaari, Chief Legal Officer Minja Salmio and interim Chief Financial Officer Laura Pulkkinen. The changes are effective immediately.
For further information, please contact:
Teemu Suna, CEO
Oaklins Merasco Ltd, tel. +358 9 6129 670
Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.